Epstein Secrets

500.000 151.575 164,970 -1.335.030 Avalanche Biotechnoiegles now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc

cost basis I • EFTA00811546 Purchase Quantity 6/30117 7131117 Unrealized Asset Description Date Cost Value Value Gain (Loss) . . — Haze Trust - Fixed income (DA)3,, -- JP Morgan Chase 7.9% Pfd 4/30/2049 JPM Tr Fit Rate Income Fund 05/10/11 01/22/13 3.000,000 240.973.957 3337.958 2.413,469

,000 151,575 164,970 -1.335.030 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 2

538,973 51,691 135,985,107 EFTA00811554 Purchase Quantity 6/30/17 741117 Unrealized Gain (Lose) Asset Description Date Coet Value Value Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% Pfd 4/30/2049 05/10/11 3,000,000 3.337,958 3,158,000 3,112.500 -225,456 JPM Tr Pk Rate Income Fund 01/22/13

.500.000 124,785 151,575 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen I

826,766 51,690 127,228,936 EFTA00811532 Purchase Quantity 5/31/17 6130117 Unrealized Asset Description Dab Cost Value Value Gain (Lose) Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% PM 4/30/2049 05/10/11 3,000300 3,337,958 3,133,150 3 -179,958 JPM Tr Fit Rate Income Fund 01/22/13 240.30339

o Global Management 3/31/11 263,157 4,999,983 8,807,865 9,407,863 4,407,880 Broadcom Ltd 10/13/17 4,000 985,931 1,027,600 992,120 6,189 BASF ADR 4/13/15 5,000 508,056 549,400 586,000 77,944 Blogen Idec Inc 2/14/12 2,095 250.455 667,404 728.662 478,207 Centene Corp W8/14 15,550

78 1,336.634 107,909,055 EFTA00811669 Purchase Quantity 12/31/17 1131/18 Unrealized Asset Description Date Cost Value Value Gain (Loss) Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% Pfd 4/30/2049 05/10/11 3000000 , , 3337958 3,077,000 3,100,500 -237,458 JPM Floating Rate Income fund 01/221

/17 314,000 53,321,627 52,682,920 51,891,640 -1,429.987 Apollo Global Management 3/31/11 263.157 4.999.983 7.794.710 7.589,448 2.589.465 BASF ADR 4/13/15 5,000 508,056 507,800 521,000 12,944 Berkshire Hathaway 2/5/18 6 1,852.362 1,794,600 1,743,900 -108,482 Berkshire Hathaway 312

,329 1,258,115 93,225,893 EFTA00811708 Purchase Quantity 3131/18 4130118 Unrealized Asset Description Date Cost Value Value Gain (Loss) Haze Trust - Fixed Income (DB) Citibank Preferred Ser C 5.8% 10/28/14 49 033 1 180 739 1 246 419 1 237,103 56 364 'Wank Preferred Ser 5.8 10129/14 150,987 3

,000 151,575 164,970 -1.335.030 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 2

538,973 51,691 135,985,107 EFTA00617224 Purchase Quantity 6/30/17 741117 Unrealized Gain (Lose) Asset Description Date Coet Value Value Haze Trust - Fixed Income (DB) JP Morgan Chase 7.9% Pfd 4/30/2049 05/10/11 3,000,000 3.337,958 3,158,000 3,112.500 -225,456 JPM Tr Pk Rate Income Fund 01/22/13